Étiquette : ABD-0171
-
Advanced BioDesign Publishes Groundbreaking Study in Cell Chemical Biology Introducing ABD-0171, a Next-Generation ALDH1 Inhibitor for Resistant Solid Tumors
Lyon, France – October 1st, 2025 – – Advanced BioDesign, a biotechnology company pioneering innovative cancer therapies through the inhibition of the aldehyde dehydrogenase, today announced the publication of a landmark study in Cell Chemical Biology presenting ABD-0171, its second-generation inhibitor targeting ALDH1A3, a key enzyme implicated in cancer stemness and therapeutic resistance. The study…
Advanced BioDesign 